ARON 3D_Transparent

Renal Cell Carcinoma

Adjuvant Pembro

Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study

Kopp RM,
et al. Cancer Immunol Immunother
2025
Sarcomatoid

Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study

Massari F, et al. JCO Glob Oncol
JCO Glob Oncol.
2025
Toxicity related

Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)

Molina-Cerrillo J
et al. Int J Cancer
2025
mRNA ARON 1

mRNA expression, tumor heterogeneity, and response to therapy inpatients with advanced renal cell carcinoma treated with immune-basedcombinations (ARON-1α)

Aguzzi C
et al. Biochem Biophys Rep.
2025
nivo cabo 1

Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study

Bourlon MT
et al. Front Oncol
2025
non clear

Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell RenalCell Carcinoma: Results from the ARON-1 Study

Massari F
, et al. Eur Urol Focus
2025

Do you want to join us ?

Join us today
ARON 3D_Transparent
Youtube Linkedin

Coordinated and designed by Atteggiamento Digitale .

Legal and Privacy.